Collegium Pharmaceutical's market cap is currently $959.44M. The company's EPS TTM is $2.317; its P/E ratio is 12.84; Collegium Pharmaceutical is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $1.54. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 566.77M	$ 463.93M	$ 276.87M	$ 310.02M	$ 296.70M
Gross Profit	$ 326.17M	$ 209.49M	$ 150.62M	$ 179.84M	$ 103.04M
Operating Income	$ 166.96M	$ -104.57M	$ -46.70M	$ -5.09M	$ -23.75M
EBITDA	$ 308.33M	$ 168.76M	$ 86.58M	$ 118.07M	$ -6.02M
Net Income	$ 48.16M	$ -25.00M	$ 71.52M	$ 26.75M	$ -8.15M
Balance Sheet
Cash & Short-Term Investments	$ 310.55M	$ 173.69M	$ 186.43M	$ 174.12M	$ 170.02M
Total Assets	$ 1.14B	$ 1.17B	$ 692.08M	$ 643.84M	$ 306.30M
Total Debt	$ 674.28M	$ 872.79M	$ 258.75M	$ 266.58M	$ 21.59M
Net Debt	$ 435.34M	$ 699.10M	$ 72.32M	$ 92.47M	$ -148.43M
Total Liabilities	$ 947.88M	$ 979.29M	$ 489.15M	$ 457.81M	$ 218.87M
Stockholders' Equity	$ 195.43M	$ 194.84M	$ 202.93M	$ 186.03M	$ 87.43M
Cash Flow
Free Cash Flow	$ 274.29M	$ 122.61M	$ 101.61M	$ -279.83M	$ 21.34M
Operating Cash Flow	$ 274.75M	$ 124.23M	$ 103.56M	$ 93.94M	$ 27.78M
Investing Cash Flow	$ -70.81M	$ -573.69M	$ -1.94M	$ -373.77M	$ -6.44M
Financing Cash Flow	$ -140.18M	$ 436.72M	$ -89.30M	$ 286.47M	$ 2.04M

Currency in USD

Collegium Pharmaceutical Earnings and Revenue History

Income Statement >

Collegium Pharmaceutical Debt to Assets

Balance Sheet >

Collegium Pharmaceutical Cash Flow

Cash Flow >

Collegium Pharmaceutical Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing